Calculus bovis inhibits liver cancer via the Wnt/β-catenin pathway

Figure 1 Wnt/β-catenin pathway. Dvl: Dishevelled; APC: Adenomatous polyposis coli; CK-1: Casein kinase I isoform-α; GSK3β: Glycogen synthase kinase-3; TCF/LEF1: T-cell factor/lymphoid enhancer factor-1; Ub: Ubiquitination; P: Phosphorylation.

Figure 2 Experimental processes of the published study for in vivo and in vitro experiments. A: Experiment in vivo; B: Experiment in vitro. CB: Calculus bovis; L-CB: Low-dose Calculus bovis group; M-CB: Medium-dose Calculus bovis group; H-CB: High-dose Calculus bovis group; CBS: Calculus bovis-containing serum. Adapted from the published study by Huang et al[10].